西亚试剂优势供应上万种化学试剂产品，欢迎各位新老客户咨询、选购！
中国
联系我们
联系方式：400-990-3999 / 邮箱：sales@xiyashiji.com
西亚试剂 —— 品质可靠，值得信赖
Oncogenic Nras has bimodal effects on stem cells that sustainably increase competitiveness
Qing Li，Natacha Bohin，Tiffany Wen，Victor Ng，Jeffrey Magee，Shann-Ching Chen，Kevin Shannon& Sean J. Morrison
‘Pre-leukaemic’ mutations are thought to promote clonal expansion of haematopoietic stem cells (HSCs) by increasing self-renewal and competitiveness1； however， mutations that increase HSC proliferation tend to reduce competitiveness and self-renewal potential， raising the question of how a mutant HSC can sustainably outcompete wild-type HSCs. Activating mutations in NRAS are prevalent in human myeloproliferative neoplasms and leukaemia2. Here we show that a single allele of oncogenic NrasG12D increases HSC proliferation but also increases reconstituting and self-renewal potential upon serial transplantation in irradiated mice， all prior to leukaemia initiation. NrasG12D also confers long-term self-renewal potential to multipotent progenitors. To explore the mechanism by which NrasG12D promotes HSC proliferation and self-renewal， we assessed cell-cycle kinetics using H2B–GFP label retention and 5-bromodeoxyuridine (BrdU) incorporation. NrasG12D had a bimodal effect on HSCs， increasing the frequency with which some HSCs divide and reducing the frequency with which others divide. This mirrored bimodal effects on reconstituting potential， as rarely dividing NrasG12D HSCs outcompeted wild-type HSCs， whereas frequently dividing NrasG12D HSCs did not. NrasG12D caused these effects by promoting STAT5 signalling， inducing different transcriptional responses in different subsets of HSCs. One signal can therefore increase HSC proliferation， competitiveness and self-renewal through bimodal effects on HSC gene expression， cycling and reconstituting potential.
